Nasal Obstruction Beyond 6 Weeks: Persistent, Transient, When to Worry?

Clinical approach differs dramatically by duration. Most patients say "my nose has been blocked for a while" — the "while" detail directs the diagnostic path.

Acute (≤4 weeks): typically viral upper respiratory infection (cold). With discharge + fever + sore throat; symptomatic treatment (nasal wash, ibuprofen, antihistamine if needed). Resolves in 7-14 days. Acute bacterial rhinosinusitis (ABRS) — after day 10 with purulent discharge + facial pain + fever recurrence; antibiotic (amoxicillin/clavulanate) needed. Acute allergic flare (seasonal pollen): 2-4 weeks; nasal steroid + antihistamine + allergen avoidance.

Subacute (4-12 weeks): transition from acute to persistent. Careful evaluation here — incompletely resolved acute sinusitis, chronicising allergic rhinitis, drug-induced (decongestant >5-7 days "rebound"), new-onset chronic rhinitis. ENT review advised; CT later or per indication.

Chronic (≥12 weeks): "chronic rhinitis + rhinosinusitis" classification (EPOS/EAACI). Mandatory detailed ENT + nasal endoscopy + paranasal CT + workup (allergy, cytology, IgE) + specific plan (medical or surgical). For resistant cases — multidisciplinary (ENT + allergist + pulmonologist + immunologist).

6-week threshold: this article — beyond 6 weeks represents subacute/chronic transition; ENT review should be early (waiting until 12 weeks unnecessary).

Timeline practical decisions:

• 0-2 weeks + viral signs: home care; no antibiotic; nasal wash + paracetamol.

• 2-4 weeks + discharge, fever, facial pain: possible acute sinusitis; primary care or ENT; antibiotic if indicated.

• 4-6 weeks + no resolution: first-line medical (intranasal steroid + antihistamine + nasal wash 2-week trial); continue if improving, ENT if not.

• 6+ weeks + no/insufficient response: mandatory ENT; workup + specific treatment.

• Anytime — unilateral + bleeding + hoarseness + ear fullness + weight loss: URGENT ENT (regardless of duration). We expand on the clinical framework in our general ENT services.

Structural causes disrupt nasal cavity anatomy in chronic obstruction — airflow decreases, with mucosal dryness + post-nasal drip + poor sleep.

Septal deviation: midline wall deformity. Cause — traumatic (most common; sometimes from childhood birth canal trauma), developmental, post-surgical. Typical: unilateral or alternating obstruction, post-nasal drip, supine sleep one nostril more blocked, snoring. Diagnosis: anterior rhinoscopy + endoscopy. Treatment: failed medical → septoplasty. See our septoplasty vs rhinoplasty post.

Turbinate hypertrophy (inferior): lateral wall fleshy structure; chronic allergy + irritation + drug-induced swelling + valve narrowing + idiopathic. Typical: bilateral variable obstruction, worse at night (position), transient response to decongestant spray. Treatment: medical (intranasal steroid 3-6 mo) → if no response, surgical: radiofrequency turbinate reduction (RFA), submucosal microdebrider turbinoplasty, partial turbinectomy. Total turbinectomy NOT recommended (empty-nose syndrome — paradoxical obstruction + dryness).

Alar collapse + internal-external nasal valve narrowing: weak alar cartilage or post-rhinoplasty support loss → lateral wall sucks in during inspiration. Typical: obstruction with effort (exercise) + need for high airflow; Cottle manoeuvre positive (pulling lateral wall out opens flow). Treatment: medical limited; surgical — alar batten graft, spreader graft, lateral crural strut graft (revision or functional rhinoplasty).

Adenoid hypertrophy: prominent in children + young adults; lymphoid tissue swelling in nasopharyngeal posterior wall. Typical: mouth breathing, snoring, sleep apnea, Eustachian dysfunction (middle ear effusion). Diagnosis: endoscopy, lateral nasopharyngeal X-ray. Treatment: paediatric medical (steroid) → surgical (adenoidectomy). In adults — distinguish nasopharyngeal lesion (especially in Chinese-Asian genetic background — NPC risk).

Post-traumatic deformity: old nasal fracture + healing + septal + external deformity; uni- or bilateral obstruction. Treatment: rhinoplasty (functional + aesthetic) + septoplasty combination — Prof. Dr. Hasan Ahmet Özdoğan clinic specialty.

Congenital obstruction: choanal atresia (neonatal emergency), choanal stenosis (subacute/chronic in child), nasal pyriform aperture stenosis. Mostly paediatric; rarely subclinical in adult.

Structural evaluation protocol: anterior rhinoscopy (speculum + light — outer-middle third view), fibre-optic endoscopy (full cavity + nasopharynx), Cottle manoeuvre (lateral pull — valve test), modified Cottle (alar support), peak nasal inspiratory flow (PNIF — objective), nasal valve assessment (3D face analysis), paranasal CT (if needed — structure + sinus combined).

Chronic nasal mucosal inflammation is the commonest adult obstruction cause. EPOS 2020 defines chronic rhinosinusitis (CRS) with/without polyp subtypes.

Chronic rhinitis (CR — without sinus involvement): nasal discharge, obstruction, sneezing, post-nasal drip; 12+ weeks. Subtypes: allergic (commonest — IgE-mediated), non-allergic (vasomotor, gustatory, hormonal, drug-induced), mixed. Diagnosis: history + allergy test (skin-prick or IgE) + rhinoscopy + endoscopy. Treatment: allergic — avoidance + intranasal steroid (mometasone, fluticasone — daily 3-6 mo) + antihistamine (2nd-gen oral or intranasal) + immunotherapy (subcutaneous or sublingual — long-term curative); non-allergic — intranasal steroid + ipratropium spray + workup.

Chronic rhinosinusitis without polyps (CRSsNP): nasal + paranasal sinus inflammation; no polyps; 12+ weeks. Typical: obstruction + discharge + facial pain/pressure + smell reduction (≥2/4 symptoms). Causes: allergy, smoking, chronic infection, anatomic obstruction (osteomeatal complex). Treatment: 3-6 months intensive medical (intranasal steroid + saline irrigation + macrolide antibiotic low-dose long-course + allergy management) → if failed, FESS (functional endoscopic sinus surgery).

CRS with polyps (CRSwNP): polyps in nasal cavity / ethmoid + sinus inflammation. Type-2 eosinophilic inflammation (Th2 — IL-4, IL-5, IL-13 mediated). Comorbidities: asthma (Samter's triad: polyp + asthma + aspirin intolerance), allergy, allergic fungal sinusitis. Typical: bilateral obstruction (mechanical), full/severe smell loss (anosmia/hyposmia — most prominent), post-nasal drip, pressure. Treatment: intranasal steroid + systemic steroid courses (flares), saline wash, macrolide, biologics (dupilumab, omalizumab, mepolizumab — newer — Type-2 immune blockers) — FESS + medical maintenance. Polyp recurrence high (40%+ at 5 years), long-term follow-up.

Atrophic rhinitis (ozena): nasal mucosal atrophy + thick dark crust + foul odour. Causes: idiopathic (primary — especially developing countries), secondary (post-radiotherapy, excessive surgery — empty nose syndrome, autoimmune, iron deficiency). Paradox: wide nasal cavity but obstruction sensation (mucosal "airflow sensing" disrupted). Treatment: routine saline irrigation + humidification + topical antibiotic (crust + bacterial colonisation), iron supplement (if deficient), surgical (Young's procedure — nasal valve closure — last resort).

Rhinitis medicamentosa (drug-induced): decongestant nasal spray (oxymetazoline, xylometazoline) >5-7 days causes rebound vasoconstriction → obstruction. Common (patient unaware). Treatment: stop spray + intranasal steroid + oral antihistamine 4-6 weeks; gradual taper. Patient education — decongestant spray <3 days only.

Allergic fungal rhinosinusitis (AFRS): allergic mucin (thick sticky), polyps, immune-mediated inflammation. Typical: child-young adult, atopy, anosmia, characteristic CT (heterogeneous sinus content, bone expansion). Treatment: FESS + oral steroid + AIT or biologics.

Systemic disease link: sarcoidosis (granuloma + sinus wall involvement + skin + lung), granulomatosis with polyangiitis (vasculitis + septal perforation + skin + kidney), Churg-Strauss (asthma + eosinophilia + systemic vasculitis), cystic fibrosis (mucociliary defect — paediatric). Workup: ANCA, ACE, eosinophils, complement, immune panel, biopsy if needed. For the related clinical reference, see septum deviation page.

The most critical category in chronic nasal obstruction is nasal/nasopharyngeal tumour — because early diagnosis + treatment largely determines prognosis. Unilateral + persistent + extra symptoms (bleeding, pain, ear fullness, vision change, neck mass, weight loss) raise suspicion.

Benign tumours:

(A) Nasal papilloma — inverted, exophytic, columnar type; HPV-associated; unilateral cavity growth; 5-15% malignant transformation (higher in inverted). Diagnosis: endoscopy + biopsy + CT + MR. Treatment: full surgical removal (endoscopic or endonasal); critical follow-up (recurrence + malignant transformation).

(B) Juvenile nasopharyngeal angiofibroma: adolescent male; unilateral obstruction + recurrent epistaxis; can destroy bone. Diagnosis: MR (vascular), CT, angiography. Treatment: preoperative embolisation + endoscopic resection.

(C) Dermoid cyst, lipoma, fibroma, neurofibroma: rare, local.

Malignant tumours:

(A) Sinonasal squamous cell carcinoma (SCC): adult, unilateral obstruction + bleeding + facial pain + sometimes facial swelling + tooth pain + diplopia. Risks: smoking, occupational (wood dust, nickel, chrome). Diagnosis: endoscopy + biopsy + CT/MR. Treatment: surgery (endoscopic or combined) + radiotherapy ± chemotherapy.

(B) Esthesioneuroblastoma (olfactory neuroblastoma): upper nasal cavity (cribriform plate); smell loss + unilateral obstruction; rare but important (intracranial spread). Diagnosis: MR + biopsy.

(C) Sinonasal undifferentiated carcinoma, adenocarcinoma, lymphoma: rarer.

(D) Nasopharyngeal carcinoma (NPC): nasopharyngeal lesion — special category; Chinese-South Asian genetic + EBV-related; less common but seen in Türkiye. Typical: unilateral hearing loss (middle-ear effusion — Eustachian blockage), neck lymphadenopathy (especially posterior triangle), epistaxis, cranial nerve involvement (vision, face — late). Diagnosis: nasopharyngeal endoscopy + biopsy + MR + EBV serology + neck ultrasound + cyst biopsy if needed. Treatment: radiotherapy (primary) + chemotherapy; follow-up for local recurrence/distant metastasis.

Systemic causes:

(A) Sarcoidosis: granuloma + sinus wall involvement + skin + lung + lacrimal glands. Diagnosis: ACE, calcium, chest CT, biopsy (skin or lung). Treatment: steroid.

(B) Granulomatosis with polyangiitis (GPA, formerly Wegener): vasculitis + septal perforation (classic!) + lower airway + kidney. Diagnosis: ANCA (c-ANCA, PR3), biopsy. Treatment: immunosuppression (rituximab, cyclophosphamide).

(C) Microscopic polyangiitis, Churg-Strauss, polyarteritis nodosa: vasculitis subtypes; nasal involvement rare.

(D) Cystic fibrosis: nasal polyps + sinusitis + lung; child-young adult. Diagnosis: sweat test, genetics.

(E) Immune deficiency (primary or HIV): recurrent sinusitis + rare pathogens.

Smoking and obstruction: heavy smoking (30+ pack-year) raises chronic rhinitis + early malignancy risk. Obstruction + hoarseness + sore throat + neck mass + weight loss combination → ENT-oncology review. Smoking cessation support + ENT follow-up.

Standard ENT evaluation: detailed history → exam → endoscopy → imaging (if needed) → workup (if needed) → biopsy (if needed) → treatment plan.

History: duration (acute/subacute/chronic), pattern (constant/variable/uni-bilateral), associated symptoms (discharge colour-smell, pain, smell-taste change, ear fullness, voice, throat, weight, fever), triggers (season, pets, smoking, chemicals), drugs (especially decongestant spray, oral contraceptive, ACE-i, beta-blocker), prior surgery (rhinoplasty, septoplasty, sinus surgery), trauma, family (allergy, polyps, cancer), occupation + hobbies (dust, chemical, wood), smoking + alcohol, systemic disease.

Examination: external nose (deviation, depression, asymmetry), Cottle manoeuvre (lateral wall), modified Cottle (alar support), anterior rhinoscopy (speculum — anterior third), oral cavity (post-nasal drip, palate), neck (lymphadenopathy), ear (otoscopy — effusion), eye (lower lid + epiphora — sinus pressure).

Nasal endoscopy (fibre-optic or rigid): standard ENT office procedure. Topical anaesthesia (lidocaine + decongestant), 3 mm flexible or rigid endoscope. Full nasal cavity — septum, turbinates, osteomeatal complex, nasopharynx (Eustachian opening + adenoid + tumour screen). Unilateral obstruction always requires nasopharyngeal evaluation.

Imaging — paranasal CT (non-contrast): standard indication — chronic rhinosinusitis predominant, failed medical treatment, polyps + sinus disease, anatomic abnormality suspicion, preoperative planning (FESS, septoplasty). Low-dose protocol available.

Imaging — MR (contrast): tumour suspicion (soft tissue detail, intracranial extension), nasopharyngeal lesion, allergic fungal sinusitis (characteristic), skull base involvement.

Imaging — angiography: vascular lesion (angiofibroma) preoperative embolisation.

Workup: total IgE, specific IgE (allergen panel), skin-prick test, CBC + eosinophil + differential, ANCA (vasculitis suspicion), ACE + calcium (sarcoidosis), nasal cytology (allergic vs non-allergic vs eosinophilic vs infectious rhinitis), nasal culture + antibiotic sensitivity (acute bacterial sinusitis complication), bilirubin + liver panel (systemic), HIV (appropriate clinic), sweat test (cystic fibrosis paediatric).

Biopsy: when suspicious lesion seen during endoscopy — atypical polyp, asymmetric, bleeding, firm, ulceration. Pathology + advanced studies. Local or general anaesthesia depending on extent.

Treatment plan — by evaluation result:

(A) Structural abnormality: surgery (septoplasty, turbinoplasty, functional rhinoplasty, adenoidectomy).

(B) Allergic rhinitis: avoidance + intranasal steroid + antihistamine + immunotherapy.

(C) Non-allergic rhinitis: intranasal steroid + ipratropium + workup.

(D) CRSsNP: 3-6 months intensive medical + FESS if failed.

(E) CRSwNP: intranasal steroid + systemic steroid courses + saline wash + biologic + FESS + medical maintenance.

(F) Tumour: surgery ± radiotherapy ± chemotherapy (oncology multidisciplinary).

(G) Systemic: specific treatment (steroid, immunosuppressant, biologic) + ENT follow-up.

ENT access in Türkiye: public (hospital ENT clinics), private (specialist clinic + private hospital), university hospital (complex cases). Prof. Dr. Hasan Ahmet Özdoğan clinic — ENT + head-and-neck surgery + oncology specialist; reference for complex cases + surgical planning + second opinion. Single visit detailed endoscopy + planned imaging + written treatment plan + long-term follow-up. We share patient experiences on our Istanbul ENT services.